Keynote comment: Cancer drug pricing in the USA

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)444-445
Number of pages2
JournalLancet Oncology
Volume7
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Physicians' Practice Patterns
Persuasive Communication
Guideline Adherence
Drug Costs
Medical Oncology
Cost Control
Drug Industry
Practice Guidelines
Antineoplastic Agents
Costs and Cost Analysis
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Keynote comment : Cancer drug pricing in the USA. / Johnson, David H.

In: Lancet Oncology, Vol. 7, No. 6, 06.2006, p. 444-445.

Research output: Contribution to journalArticle

@article{cfbb7f5d1701410e8e177dd5a35c8973,
title = "Keynote comment: Cancer drug pricing in the USA",
author = "Johnson, {David H.}",
year = "2006",
month = "6",
doi = "10.1016/S1470-2045(06)70702-1",
language = "English (US)",
volume = "7",
pages = "444--445",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "6",

}

TY - JOUR

T1 - Keynote comment

T2 - Cancer drug pricing in the USA

AU - Johnson, David H.

PY - 2006/6

Y1 - 2006/6

UR - http://www.scopus.com/inward/record.url?scp=33646874387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646874387&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(06)70702-1

DO - 10.1016/S1470-2045(06)70702-1

M3 - Article

C2 - 16750490

AN - SCOPUS:33646874387

VL - 7

SP - 444

EP - 445

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 6

ER -